@article {1438,
	title = {Phytoflavonoids-A Future Perspective for the Therapeutic Potential of Alzheimer{\textquoteright}s Disease},
	journal = {Pharmacognosy Research},
	volume = {17},
	year = {2025},
	month = {June 2025},
	pages = {788-795},
	type = {Review Article},
	chapter = {788},
	abstract = {<p class="rtejustify">Millions of people suffer from the neurodegenerative diseases like Alzheimer{\textquoteright}s Disease (AD) worldwide. Due to their complex pathology, no effective pharmacological treatment has been found to date, despite extensive research. Developing new, effective therapeutic agents to cure these disease remains a major challenge. Although the cause of AD remains apparent, numerous studies indicates that oxidative stress and neuro-inflammation lead to neurodegeneration in the central nervous system and play vital role in AD morbidity and progression. Flavonoids, which are found widely in nature, exhibit anti-oxidative, anti-inflammatory, anti-mutative, anti-microbial, and neuroprotective properties, so have potential to treat these two kinds of disease. In this review, we focus on the anti-oxidative and neuroprotective action of flavonoids in attenuating Alzheimer{\textquoteright}s disease, and how they might be harnessed in the development of new pharmacological agents to treat these diseases. Some Flavonoids compounds Quercetin, Rutin, hesperidin, Naringinin, Epigallocatechin-3-gallate, displayed to be effective in AD. Considerable studies have demonstrated the anti-AD effects of flavonoids through various in vitro and in vivo models. However, more rigorous studies are needed to be done for flavonoids to develop into effective drugs and apply them to clinical practice.</p>
},
	keywords = {Alzheimer{\textquoteright}s disease, Flavonoids, Neuroprotective, Quercetin, Rutin},
	doi = {10.5530/pres.20252213},
	author = {Karthigadevi Kamalakannan and Shanmuganathan Seetharaman and Anbazhagan Sockalingam and K Reeta VijayaRani and Kavimani Subramanian}
}
